Premium
Grade 1‐2 neutropenia after first treatment for diffuse large B ‐cell lymphoma is associated with a better outcome compared to grade 3‐4—A D anish population‐based cohort study
Author(s) -
Clausen M.R.,
Ulrichsen S.P.,
Nørgaard M.,
d'Amore F.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_71
Subject(s) - medicine , neutropenia , diffuse large b cell lymphoma , hazard ratio , proportional hazards model , rituximab , lymphoma , gastroenterology , population , chemotherapy , febrile neutropenia , oncology , surgery , confidence interval , environmental health